Product Description:

• Trelegy Ellipta 200/62.5/25 mcg is a combination inhalation powder used for long-term management of chronic obstructive pulmonary disease (COPD) and asthma.


• Contains three active ingredients: fluticasone furoate (inhaled corticosteroid), umeclidinium (long-acting muscarinic antagonist), and vilanterol (long-acting beta-agonist) for comprehensive respiratory control.


• Helps reduce inflammation, relax airway muscles, and improve breathing over a 24-hour period.


• Delivered via the Ellipta inhaler for precise dosing and ease of use.


• Pack contains 30 doses, providing approximately one month of treatment when used once daily.

How To Use:

• Use exactly as prescribed by your healthcare professional, typically once daily at the same time each day.


• Open the cover of the Ellipta inhaler to prepare a dose and inhale deeply through the mouthpiece.


• Do not exhale into the inhaler or shake it before use.


• Rinse your mouth with water after inhalation to reduce the risk of oral thrush.


• Follow your doctor’s instructions regarding regular monitoring and use of other COPD or asthma medications.

Warnings And Precautions:

• Not recommended for sudden asthma attacks or acute respiratory distress.


• Use with caution in patients with heart disease, high blood pressure, or thyroid disorders.


• Report any signs of worsening breathing, chest pain, or allergic reactions immediately.


• Do not stop treatment abruptly without consulting your healthcare provider.


• Keep out of reach of children and store at room temperature away from moisture and heat.

Ingredients:

• Active ingredients: Fluticasone furoate 200 mcg, Umeclidinium 62.5 mcg, Vilanterol 25 mcg per inhalation.


• Inactive excipients to stabilize the powder and ensure proper aerosolization.


• Ellipta inhaler device components made of medical-grade plastic and metal.


• Other pharmaceutical-grade excipients approved for inhalation use.


• No preservatives are included in the inhalation powder.